CTRI/2024/03/064562
Not yet recruiting
Phase 2
A Pilot Study to evaluate the Clinical Efficacy of an Ayurvedic Treatment Module in the Management of Multiple Sclerosis ( Sarvanga Gatavata) - NI
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: G35- Multiple sclerosis
- Sponsor
- All India Institute of Ayurveda
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who are fit to undergo Snehapana, Virechana, Swedana,Basti and Nasya Karma.
- •2\.Diagnosed cases of Multiple Sclerosis with MRI , continuing allopathic medication and EDSS score less than 8\.
- •3\. ICD code: G \- 35
- •4\. Socio\- economic status: All
Exclusion Criteria
- •1\. Cardiac disease, pulmonary tuberculosis, severe lung disease, diabetes and pregnant women, exposed skin related disease.
- •2\.EDSS score more than 8 .
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A Pilot Study to compare the Clinical Effectiveness of Dental Implant made in India with a Standard Benchmarked ImplantCTRI/2023/04/051641Translational Center of Excellence on Biomaterials for Orthopedic and Dental Applications
Not yet recruiting
Not Applicable
A Study to Evaluate the Efficacy of Phellinus linteus Extract on Knee Articulation HealthDiseases of the musculo-skeletal system and connective tissueKCT0004266Cheonan Korean Medicine Hospital of Daejeon University24
Completed
Not Applicable
A pilot clinical trial to evaluate the efficacy of acupuncture therapy and Needle-Embedding acupuncture therapy on Atopic DermatitisDiseases of the skin and subcutaneous tissueKCT0003177DONGSHIN UNIVERSITY SUNCHEON ORIENTAL MEDICINE HOSPITYA14
Not yet recruiting
Phase 2
Vel Tooth powder against dental biofilm and Gingival bleeding among ChildreCTRI/2023/09/058077ational Institute of Siddha
Active, not recruiting
Not Applicable
Study to investigate the effect of AP301 on treatment of primary graft dysfunction (PGD) after primary lung transplantatioEUCTR2013-000716-21-ATApeptico Forschung und Entwicklung GmbH